Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
opioid |
| gptkbp:activeIngredient |
hydrocodone
|
| gptkbp:approvedBy |
1943
|
| gptkbp:ATCCode |
N02AA55
|
| gptkbp:brand |
gptkb:Norco
gptkb:Lortab gptkb:Vicodin |
| gptkbp:CASNumber |
125-29-1
|
| gptkbp:combinationProduct |
gptkb:ibuprofen
acetaminophen |
| gptkbp:controlledSubstanceSchedule |
gptkb:Schedule_II_(US)
|
| gptkbp:developedBy |
gptkb:Knoll_Pharmaceuticals
|
| gptkbp:excretion |
kidneys
|
| gptkbp:hasMolecularFormula |
C18H21NO3·C4H6O6
|
| gptkbp:hasSaltForm |
bitartrate
|
| https://www.w3.org/2000/01/rdf-schema#label |
hydrocodone bitartrate
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:riskFactor |
addiction
overdose |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
constipation drowsiness respiratory depression |
| gptkbp:UNII |
6YKS4Y3WQ7
|
| gptkbp:usedFor |
pain management
cough suppression |
| gptkbp:bfsParent |
gptkb:Hysingla_ER
|
| gptkbp:bfsLayer |
7
|